486 related articles for article (PubMed ID: 3514684)
21. Ammoniacal silver staining of lymph node cells. I. its potential value for the diagnosis of Hodgkin's disease.
Rengifo E; Quintero S; Marinello Z
Neoplasma; 1983; 30(4):469-73. PubMed ID: 6193436
[TBL] [Abstract][Full Text] [Related]
22. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
Kamel OW; Gelb AB; Shibuya RB; Warnke RA
Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
[TBL] [Abstract][Full Text] [Related]
23. Detection of B- and T-cells in paraffin-embedded tissue sections. Diagnostic utility of commercially obtained 4KB5 and UCHL-1.
Clark JR; Williams ME; Swerdlow SH
Am J Clin Pathol; 1990 Jan; 93(1):58-69. PubMed ID: 2403743
[TBL] [Abstract][Full Text] [Related]
24. Morphologic and immunocytochemical evaluation of 220 fine needle aspirates of malignant lymphoma and lymphoid hyperplasia.
Sneige N; Dekmezian RH; Katz RL; Fanning TV; Lukeman JL; Ordoñez NF; Cabanillas FF
Acta Cytol; 1990; 34(3):311-22. PubMed ID: 2111624
[TBL] [Abstract][Full Text] [Related]
25. Malignant pleural effusion in Hodgkin's lymphoma. Report of a case with immunoperoxidase studies.
Peterson IM; Raible M
Acta Cytol; 1991; 35(3):300-5. PubMed ID: 1710403
[TBL] [Abstract][Full Text] [Related]
26. Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain.
Stein H; Hansmann ML; Lennert K; Brandtzaeg P; Gatter KC; Mason DY
Am J Clin Pathol; 1986 Sep; 86(3):292-7. PubMed ID: 3529924
[TBL] [Abstract][Full Text] [Related]
27. Leu M1 and peanut agglutinin stain the neoplastic cells of Hodgkin's disease.
Hsu SM; Jaffe ES
Am J Clin Pathol; 1984 Jul; 82(1):29-32. PubMed ID: 6741873
[TBL] [Abstract][Full Text] [Related]
28. Sensitivity of anti-Leu-M1 as a marker in Hodgkin's disease.
Frierson HF; Innes DJ
Arch Pathol Lab Med; 1985 Nov; 109(11):1024-8. PubMed ID: 3840354
[TBL] [Abstract][Full Text] [Related]
29. Immunopathology of Hodgkin's disease. Characterization of Reed-Sternberg cells with monoclonal antibodies.
Strauchen JA; Dimitriu-Bona A
Am J Pathol; 1986 May; 123(2):293-300. PubMed ID: 3085509
[TBL] [Abstract][Full Text] [Related]
30. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
[TBL] [Abstract][Full Text] [Related]
31. Coexisting Hodgkin's disease and mycosis fungoides. Immunohistochemical proof of its existence.
Simrell CR; Boccia RV; Longo DL; Jaffe ES
Arch Pathol Lab Med; 1986 Nov; 110(11):1029-34. PubMed ID: 3096258
[TBL] [Abstract][Full Text] [Related]
32. Anti-Leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.
Oka K; Mori N; Kojima M
Arch Pathol Lab Med; 1988 Feb; 112(2):139-42. PubMed ID: 3257383
[TBL] [Abstract][Full Text] [Related]
33. The "syncytial variant" of nodular sclerosing Hodgkin's disease.
Strickler JG; Michie SA; Warnke RA; Dorfman RF
Am J Surg Pathol; 1986 Jul; 10(7):470-7. PubMed ID: 2425645
[TBL] [Abstract][Full Text] [Related]
34. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas.
Miettinen M; Franssila KO; Saxén E
Cancer; 1983 Jun; 51(12):2293-300. PubMed ID: 6850508
[TBL] [Abstract][Full Text] [Related]
35. Lymphocyte predominance Hodgkin's disease: a reappraisal based upon histological and immunophenotypical findings in relapsing cases.
Regula DP; Weiss LM; Warnke RA; Dorfman RF
Histopathology; 1987 Nov; 11(11):1107-20. PubMed ID: 3692445
[TBL] [Abstract][Full Text] [Related]
36. Expression of vimentin and epithelial membrane antigen in human malignant lymphomas.
Sarker AB; Akagi T; Yoshino T; Hoshida Y; Takahashi K; Horie Y
Acta Pathol Jpn; 1990 Aug; 40(8):581-7. PubMed ID: 2239313
[TBL] [Abstract][Full Text] [Related]
37. Leu-M1 antigen expression in T-cell neoplasia.
Wieczorek R; Burke JS; Knowles DM
Am J Pathol; 1985 Dec; 121(3):374-80. PubMed ID: 3907362
[TBL] [Abstract][Full Text] [Related]
38. Bauhinia purpurea--a new paraffin section marker for Reed-Sternberg cells of Hodgkin's disease. A comparison with Leu-M1 (CD15), LN2 (CD74), peanut agglutinin, and Ber-H2 (CD30).
Sarker AB; Akagi T; Jeon HJ; Miyake K; Murakami I; Yoshino T; Takahashi K; Nose S
Am J Pathol; 1992 Jul; 141(1):19-23. PubMed ID: 1352944
[TBL] [Abstract][Full Text] [Related]
39. Enhanced staining for Leu M1 (CD15) in Hodgkin's disease using a secondary antibody specific for immunoglobulin M.
LeBrun DP; Kamel OW; Dorfman RF; Warnke RA
Am J Clin Pathol; 1992 Jan; 97(1):135-8. PubMed ID: 1345892
[TBL] [Abstract][Full Text] [Related]
40. Anaplastic large cell lymphoma, CD30/Ki-1 positive, expressing the CD15/Leu-M1 antigen. Immunohistochemical and morphological relationships to Hodgkin's disease.
Rosso R; Paulli M; Magrini U; Kindl S; Boveri E; Volpato G; Poggi S; Baglioni P; Pileri S
Virchows Arch A Pathol Anat Histopathol; 1990; 416(3):229-35. PubMed ID: 1967860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
